PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-28.46%
Both yoy net incomes decline, with MCHP at -29.87%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-6.14%
Negative yoy D&A while MCHP is 108.76%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-109.77%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-276.09%
Negative yoy working capital usage while MCHP is 32.32%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-1590.91%
Negative yoy inventory while MCHP is 10.19%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-94.80%
Negative yoy usage while MCHP is 266.12%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Some yoy increase while MCHP is negative at -35.02%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-63.17%
Negative yoy CFO while MCHP is 19.61%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-46.89%
Negative yoy CapEx while MCHP is 40.87%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
6.95%
Purchases growth of 6.95% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-22.49%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
131.82%
Growth well above MCHP's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-271.30%
We reduce yoy invests while MCHP stands at 7.35%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-45.45%
Both yoy lines negative, with MCHP at -20.76%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-49.57%
We cut yoy buybacks while MCHP is 86.81%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.